Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$19.6B | 5.8 | 8.8% | 3.0% | 6.4% | 12.8% | 8.9% | (2.1%) | 2.5% | |
$201.0B | 6.5 | 8.3% | 1.3% | 8.6% | 12.8% | 8.2% | (1.6%) | 2.3% | |
$151.3B | 5.7 | 5.9% | (2.0%) | 7.6% | 5.6% | 5.7% | (2.7%) | 3.8% | |
$36.5B | 7.1 | 14.7% | 5.9% | 16.5% | 21.1% | 12.5% | (2.5%) | 4.2% | |
$36.1B | 7.6 | 49.4% | 38.6% | 43.4% | 41.5% | 39.8% | (0.9%) | 2.3% | |
$33.7B | 6.4 | 8.8% | (2.3%) | 9.6% | 21.1% | 9.7% | 0.1% | 4.0% | |
$27.1B | 7.3 | 49.8% | 40.6% | 42.0% | (613.8%) | 48.8% | (1.4%) | 3.1% | |
$22.2B | 5.9 | 19.4% | 10.3% | 16.7% | 37.2% | 17.5% | 0.3% | 0.1% | |
$21.2B | 6.1 | 6.0% | (2.4%) | 7.4% | 9.2% | 5.9% | (2.3%) | 2.3% | |
$18.5B | 3.5 | (44.9%) | (55.3%) | (6.1%) | (25.0%) | (19.6%) | 6.7% | N/A | |
$13.9B | 6.1 | 34.6% | 25.9% | 18.6% | (58.3%) | 26.5% | (2.8%) | 0.7% |
The Quest Diagnostics Incorporated (DGX) ROIC is 8.8%, compared to the industry median of (3.1%) and the 5-year historical average of 12.0%.
The Quest Diagnostics Incorporated (DGX) ROIC minus WACC is 3.0%, compared to the industry median of ((5.2%)) and the 5-year historical average of 6.6%.
The Quest Diagnostics Incorporated (DGX) ROE is 12.8%, compared to the industry median of ((0.3%)) and the 5-year historical average of 19.9%.
The Quest Diagnostics Incorporated (DGX) ROCE is 8.9%, compared to the industry median of (2.8%) and the 5-year historical average of 11.2%.